Clinical Trial Update: Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is evaluating olaparib in combination with cediranib or AZD6738 for advanced or metastatic germline BRCA-mutated breast cancer and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• AZD6738 (ceralasertib)
• Cediranib (Cediranib)
• Lynparza (olaparib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8 | Phase 2 | Status: RECRUITING